Temporal features of brain network dynamics may provide candidate imaging markers for distinguishing PD and PSP while offering mechanistic insights into non‐motor symptomatology, however, their diagnostic applicability requires validation in independent external multicenter cohorts.
Abstract
ABSTRACT Background Dynamic analysis of resting‐state fMRI (rs‐fMRI) offers a novel approach to differentiate Parkinson's disease (PD) from progressive supranuclear palsy (PSP) by capturing temporal features of brain network activity, which may shed light on the mechanisms underlying non‐motor symptoms. Objectives To characterize differences in brain dynamics between PD and PSP using dynamic brain metrics, evaluate their exploratory discriminative performance, and investigate associations with non‐motor symptoms. Methods Sixty‐nine healthy controls, 82 PD patients, and 29 PSP patients underwent standardized clinical assessment and rs‐fMRI. Hidden Markov models extracted temporal features including fraction occurrence (FO), dwell time, and transition probability. These metrics were used for group comparisons, correlation analyses, and machine learning classification. Results PD and PSP showed opposite trends in fraction occurrence of unimodal network‐dominant states. Compared to PD and controls, PSP exhibited prolonged duration in the dorsal attention and limbic network (DAN&LIM) state and increased occurrence in the dorsal attention and frontoparietal control network (DAN&FPCN) state. Reduced unimodal state occupancy correlated with cognitive decline in both groups, while increased DAN&LIM and unimodal persistence linked to worse mood and sleep disturbances in PSP. Machine learning with these metrics achieved moderate accuracy in differentiating PD from PSP. Conclusions Temporal features of brain network dynamics may provide candidate imaging markers for distinguishing PD and PSP while offering mechanistic insights into non‐motor symptomatology. However, their diagnostic applicability requires validation in independent external multicenter cohorts.
The pathology of PSP causes clinically relevant changes in neural temporal dynamics, leading to a greater proportion of time in inefficient brain-states, leading to a greater proportion of time in networks associated with higher cognitive functions.
D. Whiteside, P. S. Jones, B. Ghosh et al.· 0 citations
Objective This study aimed to investigate the characteristics of brain functional activation during a hand grasping task in patients with Parkinson's Disease (PD) using functional near-infrared spectroscopy (fNIRS), and to further explore the clinical factors associated with the level of regional brain activation. Meth...
Kai-Li Wang, Jing Guo, Dan Liu et al.· Frontiers in Aging Neuroscie...· 0 citations
Parkinson's disease (PD) and multiple system atrophy (MSA) are alpha-synuclein-related neurodegenerative disorders with overlapping motor and non-motor symptoms but distinct pathology, clinical management, and prognosis. Early differential diagnosis, particularly between PD and the parkinsonian subtype of MSA (MSA-P),...
Dai-Chao Chen, Hua-Da Tang, Yan-Fei Pan et al.· NeuroImage: Clinical· 0 citations
ABSTRACT Background Parkinson's disease (PD) is predominantly characterized by unilateral motor manifestations and heterogeneous treatment responses. Combining single‐pulse transcranial magnetic stimulation with electroencephalography (TMS‐EEG) enables sensitive detection of cortical plasticity and dynamic brain networ...
Han Liu, Bo Jiang, Xiao Yang et al.· CNS Neuroscience & Therapeut...· 0 citations
Both the temporal expression and kinetic accessibility of state D were positively correlated with Montreal Cognitive Assessment scores, suggesting that this integrated configuration underpins high-order cognitive function and may serve as a neural marker of cognitive resilience in Parkinson's disease.
Yu-Xin Wang, Zhen Zhang, Jiang Wang et al.· Brain Communications· 0 citations
These network-specific, hemisphere-sensitive measures may serve as biomarkers for diagnosis, tracking, and prognosis of cognitive decline, and could inform personalized network-targeted neuromodulation in AD.
G. Bertazzoli, E. Canu, C. Bagattini et al.· Alzheimer's Research & T...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.